The effects and mechanisms of natural products on Helicobacter pylori eradication

Front Cell Infect Microbiol. 2024 Feb 28:14:1360852. doi: 10.3389/fcimb.2024.1360852. eCollection 2024.

Abstract

Helicobacter pylori (H. pylori) eradication is pivotal for alleviating gastric mucosal inflammation and preventing the progression of gastric diseases. While antibiotic-based therapies have achieved significant success in H. pylori eradication, challenges such as antibiotic resistance, drug toxicity, side effects, nonadherence, inapplicability, and disruption of gastrointestinal microflora have emerged. Updated therapies are urgently needed to suppress H. pylori. Nature has provided multitudinous therapeutic agents since ancient times. Natural products can be a potential therapy endowed with H. pylori eradication efficacy. We summarize the basic information, possible mechanisms, and the latest research progress of some representative natural products in H. pylori eradication, highlighting their safety, accessibility, efficiency, and ability to overcome limitations associated with antibiotic application. This review highlights the potential therapeutic advantages of incorporating ethnomedicine into anti-H. pylori regimens. The findings of this review may provide insights into the development of novel natural products and expand the therapeutic options available for H. pylori eradication.

Keywords: Helicobacter pylori; antibiotic resistance; complementary therapy; eradication; ethnomedicine; natural products.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Drug Therapy, Combination
  • Helicobacter Infections* / drug therapy
  • Helicobacter pylori*
  • Humans
  • Medicine, Traditional

Substances

  • Anti-Bacterial Agents

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by the Beijing-Tianjin-Hebei Basic Research Cooperation project, Beijing Natural Science Foundation of China (J230002), the National Natural Science Foundation of China (81700496), Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, and the special fund of the Beijing Clinical Key Specialty Construction Program, P. R. China (2021).